Roche partners with HookipaPharma to develop novel viral immunotherapies
ADC评论
October 21, 2022
On October 20, Roche and HookipaPharma entered into a strategic collaboration and licensing agreement to co-develop HB-700 and a second undisclosed novel arenavirus immunotherapy for
